News Spotlight : Latest Podcast
Innovation Institute CEO Joe Randolph Shares How to Build a Sustainable Model for Creating New Ideas
In this episode, Keith Figlioli of LRV Health sits down with Joe Randolph, president and CEO of the Innovation Institute, a highly successful joint effort between several ...
LISTEN ON ITUNES LISTEN ON SPOTIFY
News Spotlight : Latest Tweet
It's a great day for the @Phreesia team and as the first institutional investor, it's been an amazing ride watching… http://t.co/dd9aEA6905
Follow us on Twitter
News Spotlight : Latest News
Phreesia, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Phreesia, Inc. (NYSE: PHR) ("Phreesia"), a leading patient intake management platform, today announced the closing of its initial public offering of 10,681,423 shares of common stock (the "Shares"), consisting of 7,812,500 Shares issued and sold by Phreesia and 2,868,923 shares sold by certain of Phreesia's existing stockholders (the "Selling Stockholders"), which includes the full exercise of the underwriters' option to purchase 1,393,229 additional Shares from the Selling Stockholders, at a public offering price of $18.00 per share.
READ THE FULL ARTICLE
News
@LRVHealth
@LRVHealth LRVHealth
It's a great day for the @Phreesia team and as the first institutional investor, it's been an amazing ride watching… http://t.co/dd9aEA6905
@LRVHealth LRVHealth
#DigitalHealth deals and dollars jumped in Q2'19, with 130 deals accounting for $2.3B in investments according to… http://t.co/z7RQv2nUqT
@LRVHealth LRVHealth
Managing third-party risk costs the healthcare industry over $23 billion a year according to @PonemonResearch &… http://t.co/NSfxb4ivWg
LRVHealth and Portfolio News
July 22, 2019
Phreesia, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Phreesia, Inc. (NYSE: PHR) ("Phreesia"), a leading patient intake management platform, today announced the closing of its initial public offering of 10,681,423 shares of common stock (the "Shares"), consisting of 7,812,500 Shares issued and sold by Phreesia and 2,868,923 shares sold by certain of Phreesia's existing stockholders (the "Selling Stockholders"), which includes the full exercise of the underwriters' option to purchase 1,393,229 additional Shares from the Selling Stockholders, at a public offering price of $18.00 per share.
Read Full Article >July 18, 2019
Phreesia Announces Pricing of Initial Public Offering
NEW YORK (July 17, 2019) – Phreesia, Inc. ("Phreesia"), a leading patient intake management platform, today announced the pricing of its initial public offering of 9,288,194 shares of common stock at a public offering price of $18.00 per share, before underwriting discounts, consisting of 7,812,500 shares to be issued and sold by Phreesia (the "Primary Shares") and 1,475,694 shares to be sold by certain of Phreesia's existing stockholders (the "Secondary Shares" and, together with the Primary Shares, the "Shares").
Read Full Article >July 16, 2019
Diameter Health and OHIP/CliniSync HIE to Present on Methods for Successful Clinical Data Integration
Diameter Health, a market leader in clinical data integration, announced today that its President and Chief Strategy Officer, John D’Amore, will co-present alongside Adam Rossbach, Chief Technical Strategist from the Ohio Health Information Partnership (OHIP)/CliniSync HIE, in a webinar titled, “Strategies for Successful Data Integration.” The webinar will be held on Tuesday, July 23, 2019 at 1:00 p.m. ET.
Read Full Article >July 11, 2019
First Light Adds New Multimedia to Website
First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the introduction of new multimedia content on the homepage of the First Light Diagnostics website.
Read Full Article >